| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 679516 | Null | 0.00640068043275774 | 0.3081936 |
| NSC 681972 | Null | 0.00640068043275774 | 0.40741589 |
| NSC 682996 | Null | 0.00640068043275774 | 0.34355316 |
| NSC 700862 | 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- | 0.00640068043275774 | 0.31139107 |
| NSC 740357 | Null | 0.00640068043275774 | 0.018601018 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.00640068043275774 | 0.19752518 |
| NSC 748902 | [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] | 0.00640068043275774 | 0.4610919 |
| NSC 753377 | 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine | 0.00640068043275774 | 0.37785075 |
| NSC 762901 | trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide | 0.00640068043275774 | 0.32696514 |
| NSC 762908 | 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one | 0.00640068043275774 | 0.35324418 |